News Updates
More Articles
- Benefits of Integrating Patient Engagement with Diversity, Equity, and Inclusion in New Medical Product Development: A Call for Action
- Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
- Fair Pay for Patient Engagement: Navigating the Evolving Landscape of Remuneration
- Industry’s Window to Express Interest in Africa Continental Product Evaluation Pilot Closes End of February 2024
- Accelerating Adoption of eLabeling in Singapore: One Company’s Journey
Future Proofing: Key DIA GAM 2021 Themes Inform Global Pharmacovigilance and Risk Management Strategies 2022
When the DIA community gathered for DIA GAM 2021 last June, the pandemic had turned clinical safety and benefit-risk balance into household words. Both industry and governments worldwide were endeavoring to manage a flood of continuously evolving data and interpret it for the public under conditions of high uncertainty. What might this recent past mean for our future?
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!